Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Scambia

Showing results (21-30 of 1,584) with videos related to

Pageof 159
Sort By:
Expert Opinion on Investigational Drugs|March 7, 2008
New taxanes in developmentCristiano Ferlini, Daniela Gallo, Giovanni Scambia
JAMA Surgery|August 25, 2018
Reducing the Rate of Minimally Invasive Hysterectomy for Fibroids in Favor of Abdominal Surgery-There Is Always Something Evil in Good IntentionsStefano Uccella, Alex Federico, Giovanni Scambia
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|March 3, 2022
Subclinical hypothyroidism in women's health: from pre- to post-menopauseAnna Capozzi, Giovanni Scambia, Stefano Lello
Minerva Obstetrics and Gynecology|June 28, 2021
Bone metabolism in pregnancy and lactationAnna Capozzi, Giovanni Scambia, Stefano Lello
The Lancet. Oncology|September 15, 2014
Combining targeted therapies in ovarian cancerGiovanni Scambia, Vanda Salutari, Gabriella Ferrandina
The Lancet. Oncology|September 3, 2013
Controversy in treatment of advanced ovarian cancerGiovanni Scambia, Vanda Salutari, Giulia Amadio
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 20, 2016
Does ST analysis of fetal ECG reduce cesarean section rate for fetal distress?Gianluca Straface, Giovanni Scambia, Vincenzo Zanardo
Expert Opinion on Investigational Drugs|February 21, 2012
Novel targets for VEGF-independent anti-angiogenic drugsMarco Petrillo, Giovanni Scambia, Gabriella Ferrandina
Journal of Gynecologic Oncology|August 11, 2021
Author's reply to: What is the prognostic importance of lymphovascular space invasion in the absence of lymph node metastasis for early-stage endometrial cancer?Lucia Tortorella, Giovanni Scambia, Francesco Fanfani
American Journal of Obstetrics and Gynecology|September 22, 2019
ReplyStefano Uccella, Anna Fagotti, Giovanni Scambia
Pageof 159

Showing results (21-30 of 1,584) with videos related to

Sort By:
Pageof 159
Expert Opinion on Investigational Drugs|March 7, 2008
New taxanes in developmentCristiano Ferlini, Daniela Gallo, Giovanni Scambia
JAMA Surgery|August 25, 2018
Reducing the Rate of Minimally Invasive Hysterectomy for Fibroids in Favor of Abdominal Surgery-There Is Always Something Evil in Good IntentionsStefano Uccella, Alex Federico, Giovanni Scambia
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|March 3, 2022
Subclinical hypothyroidism in women's health: from pre- to post-menopauseAnna Capozzi, Giovanni Scambia, Stefano Lello
Minerva Obstetrics and Gynecology|June 28, 2021
Bone metabolism in pregnancy and lactationAnna Capozzi, Giovanni Scambia, Stefano Lello
The Lancet. Oncology|September 15, 2014
Combining targeted therapies in ovarian cancerGiovanni Scambia, Vanda Salutari, Gabriella Ferrandina
The Lancet. Oncology|September 3, 2013
Controversy in treatment of advanced ovarian cancerGiovanni Scambia, Vanda Salutari, Giulia Amadio
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 20, 2016
Does ST analysis of fetal ECG reduce cesarean section rate for fetal distress?Gianluca Straface, Giovanni Scambia, Vincenzo Zanardo
Expert Opinion on Investigational Drugs|February 21, 2012
Novel targets for VEGF-independent anti-angiogenic drugsMarco Petrillo, Giovanni Scambia, Gabriella Ferrandina
Journal of Gynecologic Oncology|August 11, 2021
Author's reply to: What is the prognostic importance of lymphovascular space invasion in the absence of lymph node metastasis for early-stage endometrial cancer?Lucia Tortorella, Giovanni Scambia, Francesco Fanfani
American Journal of Obstetrics and Gynecology|September 22, 2019
ReplyStefano Uccella, Anna Fagotti, Giovanni Scambia
Pageof 159